tiprankstipranks
Trending News
More News >
Lifeist Wellness (TSE:LFST)
:LFST

Lifeist Wellness (LFST) AI Stock Analysis

Compare
247 Followers

Top Page

TSE:LFST

Lifeist Wellness

(LFST)

Select Model
Select Model
Select Model
Neutral 41 (OpenAI - 5.2)
Rating:41Neutral
Price Target:
C$0.04
▲(7.50% Upside)
The score is driven primarily by weak fundamentals—recurring losses, consistent cash burn, and a TTM revenue consistency red flag—despite the benefit of zero debt. Technically, the stock is in a downtrend (below key moving averages with negative MACD), while the recent Amazon relaunch provides a modest positive but is not yet reflected in financial improvement.

Lifeist Wellness (LFST) vs. iShares MSCI Canada ETF (EWC)

Lifeist Wellness Business Overview & Revenue Model

Company DescriptionLifeist Wellness Inc. operates as a wellness company in the United States and Canada. The company operates CannMart.com, an online marketplace for hemp-derived CBD and accessories; and Findify, an artificial intelligence powered technology platform that offers personalized search, recommendations, and advanced data analytics for B2B ecommerce customers, as well as a butane hash oil extraction facility. It also distributes licensed and in-house branded adult-use cannabis and cannabis derived products; and supplies hardware, including vaporizers and related accessories, as well as engages in the biosciences and consumer wellness business. The company was formerly known as Namaste Technologies Inc. and changed its name to Lifeist Wellness Inc. in September 2021. Lifeist Wellness Inc. was incorporated in 2005 and is based in Vancouver, Canada.
How the Company Makes MoneyLifeist Wellness generates revenue through multiple streams. The company earns money by selling its diverse product line, which includes cannabis products, wellness technology devices, and nutraceuticals, directly to consumers through its e-commerce platforms. Additionally, Lifeist partners with various retail and distribution networks to expand its market reach. The company also explores strategic partnerships and collaborations to enhance its product offerings and tap into new markets, contributing to its revenue growth. Furthermore, Lifeist invests in research and development to innovate and introduce new products, which helps maintain a competitive edge and drive sales.

Lifeist Wellness Financial Statement Overview

Summary
Financial performance is weak: persistent net losses and ongoing negative operating/free cash flow indicate the business is not yet self-funding. While leverage is low with zero debt, equity/assets have declined and the TTM negative revenue figure is a major consistency/quality red flag.
Income Statement
18
Very Negative
Profitability remains weak across the period, with net losses in every annual report and in TTM (Trailing-Twelve-Months). While reported gross margin improved versus earlier years and revenue growth is shown as strong in TTM (Trailing-Twelve-Months), the underlying revenue level in TTM (Trailing-Twelve-Months) is negative, which raises a major quality/consistency red flag. Operating results are still loss-making, indicating the business has not yet demonstrated a stable path to sustainable earnings.
Balance Sheet
46
Neutral
Leverage is low with total debt at zero in the most recent annual period and in TTM (Trailing-Twelve-Months), which reduces financial risk. However, the balance sheet has weakened over time: equity and total assets have declined materially from earlier years, and returns on equity are consistently negative, reflecting ongoing value erosion from losses. Overall, the company has limited debt pressure but a shrinking capital base.
Cash Flow
22
Negative
Cash generation is a key concern: operating cash flow and free cash flow are negative in every period shown, including TTM (Trailing-Twelve-Months), indicating the business is consuming cash rather than funding itself internally. Free cash flow deterioration in TTM (Trailing-Twelve-Months) adds pressure, and cash burn alongside recurring losses increases reliance on external funding or further balance sheet contraction. A relative positive is that free cash flow roughly tracks reported net income, suggesting cash results are not dramatically worse than earnings quality implies—but both are still negative.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue-9.46M588.80K21.66M22.07M21.15M25.10M
Gross Profit-4.92M204.75K5.34M3.79M120.29K1.46M
EBITDA-3.05M-3.99M-5.96M-17.44M-20.25M-24.01M
Net Income-1.67M-1.45M-14.13M-15.44M-23.80M-26.25M
Balance Sheet
Total Assets2.00M5.13M13.40M20.67M37.96M39.23M
Cash, Cash Equivalents and Short-Term Investments553.66K2.34M1.45M3.80M12.74M10.28M
Total Debt0.000.001.27M328.33K554.59K755.32K
Total Liabilities708.54K1.06M9.94M7.30M11.89M10.24M
Stockholders Equity1.29M4.07M3.46M13.36M26.06M29.25M
Cash Flow
Free Cash Flow-3.05M-877.20K-2.79M-16.04M-18.64M-27.98M
Operating Cash Flow-3.05M-877.20K-2.46M-15.35M-18.28M-24.54M
Investing Cash Flow2.56M1.92M1.28K6.69M-229.57K-2.70M
Financing Cash Flow2.99K-169.19K83.82K-252.29K21.02M-284.24K

Lifeist Wellness Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.04
Price Trends
50DMA
0.05
Negative
100DMA
0.06
Negative
200DMA
0.07
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
46.10
Neutral
STOCH
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:LFST, the sentiment is Neutral. The current price of 0.04 is above the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.05, and below the 200-day MA of 0.07, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 46.10 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:LFST.

Lifeist Wellness Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
41
Neutral
C$1.33M-0.47-129.49%-98.28%76.18%
21
Underperform
C$969.81K0.44
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:LFST
Lifeist Wellness
0.04
>-0.01
-6.98%
TSE:MGW
Maple Leaf Green World
0.03
-0.02
-44.44%
TSE:WIB
West Island Brands Inc
0.13
0.00
0.00%
TSE:TCAN
TransCanna Holdings Inc
0.01
0.00
0.00%
TSE:NLV
New Leaf Ventures
0.05
0.00
0.00%
TSE:SILO
Silo Wellness Inc
0.01
0.00
0.00%

Lifeist Wellness Corporate Events

Business Operations and StrategyProduct-Related Announcements
Lifeist Wellness Relaunches Mikra Products on Amazon to Boost U.S. Market Presence
Positive
Oct 21, 2025

Lifeist Wellness Inc. has relaunched its Mikra brand on Amazon.com in the United States, introducing a lineup of performance-focused products with new formulations and branding. This move aims to enhance customer engagement and support potential wholesale partnerships and retail expansion by aligning with consumer shopping behaviors on Amazon.

Executive/Board Changes
Lifeist Wellness Announces Board Changes with New Interim Chair
Neutral
Oct 21, 2025

Lifeist Wellness Inc. announced a change to its board of directors with John Sinclair stepping down as director and chair of the audit committee. Branden Spikes, a current director with extensive experience working with Elon Musk, has been named interim chair of the audit committee, potentially bringing a fresh perspective and skill set to the company’s leadership.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025